Capstone Triton Financial Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-87
Closed -$124K 151
2020
Q4
$124K Buy
+87
New +$92.8K 0.08% 138

Other funds holding CDLX

Capstone Triton Financial Group's CDLX Position: Q1 2021 in Review

Capstone Triton Financial Group sold out of Cardlytics (CDLX) in Q1 2021, closing a stake of 87 shares — an estimated $124K sold.

Capstone Triton Financial Group first reported a position in CDLX in Q4 2020 and held it in 1 quarter. The position peaked at $124K in Q4 2020. 204 funds tracked by Wall St. Rank hold CDLX as of Q1 2021.

  • Capstone Triton Financial Group reported no remaining Cardlytics position as of Q1 2021 after selling out during the quarter.
  • Capstone Triton Financial Group sold 87 Cardlytics shares in Q1 2021, an estimated $124K.
  • Capstone Triton Financial Group first reported a position in Cardlytics in Q4 2020 and held it in 1 quarter.
  • Capstone Triton Financial Group's Cardlytics position peaked at $124K in Q4 2020.
  • 204 funds tracked by Wall St. Rank held Cardlytics as of Q1 2021.

Based on Capstone Triton Financial Group's 13F filing for Q1 2021, filed 17 May 2021.